海尔生物 (688139.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(海尔生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 2,280,896,019.231,826,339,651.431,270,455,870.90686,668,622.182,864,044,617.292,075,274,671.511,267,878,776.86563,453,088.49
 营业利润(元) 438,401,339.39395,179,711.38312,024,833.10151,342,584.47675,680,194.52514,459,068.48332,616,310.00123,178,842.83
 利润总额(元) 434,491,209.43391,622,464.17307,265,104.31151,993,528.18675,336,082.38516,097,297.03333,936,997.23124,240,596.08
 净利润(元) 412,058,658.76365,645,845.17284,211,629.04139,509,813.51611,974,028.96464,543,504.50302,270,569.64113,932,456.54
 归属于母公司股东的净利润(元) 406,073,643.93357,201,281.16278,462,841.61137,535,031.82600,791,263.18461,446,373.79300,570,997.11113,524,222.50
盈利能力:
 销售毛利率(%) 50.6350.8651.6951.0248.1547.2150.8850.53
 销售净利率(%) 18.0720.0222.3720.3221.3722.3823.8420.22
 净资产收益率(%) 9.848.817.083.50----
 总资产报酬率ROA(%) 7.467.085.613.07----
 投入资本回报率ROIC(%) 9.508.336.553.2315.0611.767.832.96
营运能力:
 存货周转率(次) 4.343.521.781.21----
 应收账款周转率(次) 13.286.066.823.98----
 总资产周转率(次) 0.410.340.240.13----
偿债能力:
 资产负债率(%) 19.6519.5721.0122.4524.4223.5426.0724.99
 股东权益比率(%) 76.5676.6175.2075.2273.2575.8573.5674.68
 已获利息倍数(倍) -17.46-25.30-27.9117.88-32.30-14.49-16.61-40.43
 流动比率 2.692.882.912.972.953.172.903.11
 速动比率 2.402.632.682.752.682.872.462.77
发展能力:
 营业收入增长率(%) -20.36-12.000.2021.8734.7236.5236.6336.22
 营业利润增长率(%) -35.12-23.19-6.1922.86-29.72-34.60-48.21-74.15
 税后利润增长率(%) -32.41-22.59-7.3621.15-28.90-33.91-47.55-72.96
 净资产增长率(%) 5.227.8610.2912.2310.9815.0315.2516.24
 总资产增长率(%) 0.676.807.8811.4312.029.5411.868.97

前瞻产业研究院